Literature DB >> 26123187

Vitamin and mineral status in patients with hyperphenylalaninemia.

Vanesa Crujeiras1, Luis Aldámiz-Echevarría2, Jaime Dalmau3, Isidro Vitoria4, Fernando Andrade5, Iria Roca6, Rosaura Leis7, Ana Fernandez-Marmiesse8, María L Couce9.   

Abstract

Natural sources of protein and some vitamins and minerals are limited in phenylketonuria (PKU) treated patients, who should receive optimal supplementation although this is not yet fully established. We conducted a cross-sectional observational multicenter study including 156 patients with hyperphenylalaninemia. Patients were stratified by age, phenotype, disease detection and type of treatment. Annual median blood phenylalanine (Phe) levels, Phe tolerance, anthropometric measurements, and biochemical parameters (total protein, prealbumin, electrolytes, selenium, zinc, B12, folic acid, ferritin, 25-OH vitamin D) were collected in all patients. 81.4% of patients had biochemical markers out of recommended range but no clinical symptoms. Total protein, calcium, phosphorus, B12, ferritin, and zinc levels were normal in most patients. Prealbumin was reduced in 34.6% of patients (74% with PKU phenotype and 94% below 18 years old), showing almost all (96.3%) an adequate adherence to diet. Selenium was diminished in 25% of patients (95% with PKU phenotype) and also 25-OHD in 14%. Surprisingly, folic acid levels were increased in 39% of patients, 66% with classic PKU. Phosphorus and B12 levels were found diminished in patients with low adherence to diet. Patients under BH4 therapy only showed significant lower levels of B12. This study shows a high percentage of prealbumin and selenium deficiencies as well as an increased level of folic acid in PKU treated patients, which should lead us to assess an adjustment for standards supplements formulated milks.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Folic acid; Nutrition; Phenylketonuria; Selenium; Tetrahydrobiopterin

Mesh:

Substances:

Year:  2015        PMID: 26123187     DOI: 10.1016/j.ymgme.2015.06.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  14 in total

Review 1.  Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.

Authors:  Ning Wang; Hor-Yue Tan; Sha Li; Yu Xu; Wei Guo; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

2.  Influence of phenylketonuria's diet on dimethylated arginines and methylation cycle.

Authors:  Fernando Andrade; Olalla López-Suárez; Marta Llarena; María L Couce; Luis Aldámiz-Echevarría
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

3.  Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods.

Authors:  Bridget M Stroup; Denise M Ney; Sangita G Murali; Frances Rohr; Sally T Gleason; Sandra C van Calcar; Harvey L Levy
Journal:  J Nutr Metab       Date:  2017-12-31

4.  Carbohydrate status in patients with phenylketonuria.

Authors:  María L Couce; Paula Sánchez-Pintos; Isidro Vitoria; María-José De Castro; Luís Aldámiz-Echevarría; Patricia Correcher; Ana Fernández-Marmiesse; Iria Roca; Alvaro Hermida; Miguel Martínez-Olmos; Rosaura Leis
Journal:  Orphanet J Rare Dis       Date:  2018-06-27       Impact factor: 4.123

5.  Health economic burden of patients with phenylketonuria (PKU) - A retrospective study of German health insurance claims data.

Authors:  Friedrich Trefz; Ania C Muntau; Kim M Schneider; Julia Altevers; Christian Jacob; Sebastian Braun; Wolfgang Greiner; Ashok Jha; Mohit Jain; Ignacio Alvarez; Paul Lane; Claudia Zeiss; Frank Rutsch
Journal:  Mol Genet Metab Rep       Date:  2021-05-13

6.  Micronutrient in hyperphenylalaninemia.

Authors:  Vanesa Crujeiras; Luís Aldámiz-Echevarría; Jaume Dalmau; Isidro Vitoria; Fernando Andrade; Iria Roca; Rosaura Leis; Ana Fermandez-Marmiesse; María L Couce
Journal:  Data Brief       Date:  2015-08-01

7.  Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.

Authors:  María L Couce; Isidro Vitoria; Luís Aldámiz-Echevarría; Ana Fernández-Marmiesse; Iria Roca; Marta Llarena; Paula Sánchez-Pintos; Rosaura Leis; Alvaro Hermida
Journal:  Orphanet J Rare Dis       Date:  2016-09-09       Impact factor: 4.123

Review 8.  Dietary intervention in the management of phenylketonuria: current perspectives.

Authors:  Júlio César Rocha; Anita MacDonald
Journal:  Pediatric Health Med Ther       Date:  2016-12-01

9.  Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study.

Authors:  Renata Mozrzymas; Dariusz Walkowiak; Sławomira Drzymała-Czyż; Patrycja Krzyżanowska-Jankowska; Monika Duś-Żuchowska; Łukasz Kałużny; Jarosław Walkowiak
Journal:  Nutrients       Date:  2020-06-14       Impact factor: 5.717

10.  One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4).

Authors:  Kristen D Brantley; Teresa D Douglas; Rani H Singh
Journal:  Orphanet J Rare Dis       Date:  2018-10-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.